Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

20 treatments under study, led by Replenish

Research Leaders

7 sponsors active, led by Alcon Research

Related Conditions

Often studied with 16 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (5)
Phase 4 (4)

Trial Status

Completed7
Enrolling By Invitation1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05626478Phase 4Completed

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

NCT06860659Phase 4Enrolling By Invitation

Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye

NCT01240122Not ApplicableCompletedPrimary

Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions

NCT01335750Not ApplicableCompletedPrimary

A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand

NCT02251561Not ApplicableCompletedPrimary

Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan

NCT01100424Not ApplicableCompletedPrimary

Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining

NCT00518700Phase 4CompletedPrimary

Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients

NCT00381446Not ApplicableUnknown

Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations

NCT00483795Phase 4CompletedPrimary

Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

Showing all 9 trials

Research Network

Common Treatments

  • Replenish1
  • Senofilcon A Contact Lens1
  • Bromfenac Sodium1
  • Sodium Citrate Sodium Chloride Sodium Borate Propylene Glycol Citrate Tetronic 1304 Amp 951
  • Unisol 41

Active Sponsors

  • Alcon Research3
  • Innovative Medical2
  • Abbott Medical Optics1
  • Department of Medical Services Ministry of Public Health of Thailand1
  • Nicole Fram M.D.1

Top Investigators

Related Conditions

  • Cme Cystoid Macular Edema1
  • Hyaluronate1
  • Tear Film Hyperosmolarity1
  • Anterior Chamber Inflammation1
  • Visual Outcome1

Activity Timeline